Collectively, these observations suggest that relieving the demand for insulin release via independent mechanisms can promote β-cell health and improve long-term outcomes [12,17], whereas β-cell exhaustion from persistently elevated insulin secretion may be an underlying cause of dysregulated secretion in T2D and contribute to the final transition to β-cell failure [17,29,216]. The gene discussed is INS; the disease is type 2 diabetes mellitus.